Imaging cell death

Journal of Nuclear Medicine

Volumn 55, Issue 1, 2014, Pages 1-4

  Neves, André A ^a   Brindle, Kevin M ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Annexin; Apoptosis; Cardiac; Necrosis; PET; Phosphatidylserine; Synaptotagmin; Tumors

Indexed keywords

1 [[1 (2 FLUOROETHYL) 1H [1,2,3] TRIAZOL 4 YL]METHYL] 5 (2 (2,4 DIFLUOROPHENOXYMETHYL) PYRROLIDINE 1 SULFONYL)ISATIN F 18; ANNEXIN; CASPASE 3; CASPASE 7; CASPASE 9; FLUORODEOXYGLUCOSE F 18; PHOSPHATIDYLSERINE; SYNAPTOTAGMIN; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; CASPASE; LIPOCORTIN 5;

ACUTE HEART INFARCTION; APOPTOSIS; ARTICLE; CELL DEATH; CELL DIFFERENTIATION; CELL GROWTH; CELL MEMBRANE; CEREBROVASCULAR ACCIDENT; DNA FRAGMENTATION; DOSIMETRY; ENZYME ACTIVATION; HUMAN; MEMBRANE DEPOLARIZATION; MITOCHONDRIAL MEMBRANE; MOLECULAR IMAGING; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TISSUE INJURY; TISSUE METABOLISM; ANIMAL; CARDIAC; CHEMISTRY; HOMEOSTASIS; METABOLISM; NECROSIS; PET; TUMORS;

ANNEXIN; APOPTOSIS; CARDIAC; NECROSIS; PET; PHOSPHATIDYLSERINE; SYNAPTOTAGMIN; TUMORS;

ANIMALS; ANNEXIN A5; APOPTOSIS; BIOLOGICAL MARKERS; CASPASES; CELL MEMBRANE; DNA FRAGMENTATION; ENZYME ACTIVATION; HOMEOSTASIS; HUMANS; MITOCHONDRIAL MEMBRANES; NECROSIS; PHOSPHATIDYLSERINES; POSITRON-EMISSION TOMOGRAPHY; SYNAPTOTAGMINS;

EID: 84894793471     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.112.114264     Document Type: Article

References (25)

1. Smith BA, Smith BD. Biomarkers and molecular probes for cell death imaging and targeted therapeutics. Bioconjug Chem. 2012;23: 1989-2006.
2. Galluzzi L, Vitale I, Abrams JM, et al. Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ. 2012;19: 107-120.
3. Kreuzaler P, Watson CJ. Killing a cancer: what are the alternatives? Nat Rev Cancer. 2012;12: 411-424.
4. Alam IS, Neves AA, Witney TH, et al. Comparison of the C2A domain of synaptotagmin-I and annexin-V as probes for detecting cell death. Bioconjug Chem. 2010;21: 884-891.
5. 18F]ICMT-11. Eur J Cancer. 2012;48: 432-440.
6. Laufer EM, Winkens MHM, Narula J, et al. Molecular imaging of macrophage cell death for the assessment of plaque vulnerability. Arterioscler Thromb Vasc Biol. 2009;29: 1031-1038.
7. Reshef A, Shirvan A, Akselrod-Ballin A, et al. Small-molecule biomarkers for clinical PET imaging of apoptosis. J Nucl Med. 2010;51: 837-840.
8. 68Ga-labeled annexin A5 as a PET imaging agent for apoptosis. Nucl Med Biol. 2011;38: 381-392.
9. Niu G, Chen X. Apoptosis imaging: beyond annexin V. J Nucl Med. 2010;51: 1659-1662.
10. 18F-labeled C2A domain of synaptotagmin I. J Nucl Med. 2011;52: 592-599.
11. Song S, Xiong C, LuW, et al. Apoptosis imaging probe predicts early chemotherapy response in preclinical models: a comparative study with F-18-FDG PET. J Nucl Med. 2013;54: 104-110.
12. 99mTc- labeling of HYNICDuramycin. Nucl Med Biol. 2012;39: 1006-1011.
13. 18F]-labeled isatin sulfonamide. Proc Natl Acad Sci USA. 2009;106: 16375-16380.
14. Nguyen QD, Lavdas I, Gubbins J, et al. Temporal and spatial evolution of therapy-induced tumor apoptosis detected by caspase-3-selective molecular imaging. Clin Cancer Res. 2013;19: 3914-3924.
15. 18F-ICMT-11, a caspase-3-specific PET tracer for apoptosis: biodistribution and radiation dosimetry. J Nucl Med. 2013;54: 1551-1556.
16. Madar I, Huang Y, Ravert H, et al. Detection and quantification of the evolution dynamics of apoptosis using the PET voltage sensor F-18-fluorobenzyl triphenyl phosphonium. J Nucl Med. 2009;50: 774-780.
17. Higuchi T, Fukushima K, Rischpler C, et al. Stable delineation of the ischemic area by the PET perfusion tracer F-18-fluorobenzyl triphenyl phosphonium after transient coronary occlusion. J Nucl Med. 2011;52: 965-969.
18. Höglund J, Shirvan A, Antoni G, et al. F-18-ML-10, a PET tracer for apoptosis: first human study. J Nucl Med. 2011;52: 720-725.
19. 18F-ML- 10. Eur J Nucl Med Mol Imaging. 2012;39: 1400-1408.
20. Cornelissen B, Kersemans V, Darbar S, et al. Imaging DNA damage in vivo using gammaH2AX-Targeted immunoconjugates. Cancer Res. 2011;71: 4539-4549.
21. Huang S, Chen HH, Yuan H, et al. Molecular MRI of acute necrosis with a novel DNA-binding gadolinium chelate: kinetics of cell death and clearance in infarcted myocardium. Circ Cardiovasc Imaging. 2011;4: 729-737.
22. Gallagher FA, Kettunen MI, Hu DE, et al. Production of hyperpolarized [1,4-13C2]malate from [1,4-13C2]fumarate is a marker of cell necrosis and treatment response in tumors. Proc Natl Acad Sci USA. 2009;106: 19801-19806.
23. Witney TH, Kettunen MI, Hu DE, et al. Detecting treatment response in a model of human breast adenocarcinoma using hyperpolarised [1-13C]pyruvate and [1,4-13C2]fumarate. Br J Cancer. 2010;103: 1400-1406.
24. Clatworthy MR, Kettunen MI, Hu DE, et al. Magnetic resonance imaging with hyperpolarized [1,4-13C2]fumarate allows detection of early renal acute tubular necrosis. Proc Natl Acad Sci USA. 2012;109: 13374-13379.
25. Bohndiek SE, Kettunen MI, Hu DE, et al. Hyperpolarized 13C spectroscopy detects early changes in tumor vasculature and metabolism after VEGF neutralization. Cancer Res. 2012;72: 854-864.